Insider Selling: Phreesia, Inc. (NYSE:PHR) SVP Sells $128,903.20 in Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 4,720 shares of the company’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $27.31, for a total transaction of $128,903.20. Following the sale, the senior vice president now directly owns 110,309 shares of the company’s stock, valued at approximately $3,012,538.79. This represents a 4.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Amy Beth Vanduyn also recently made the following trade(s):

• On Wednesday, January 15th, Amy Beth Vanduyn sold 604 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total transaction of $16,295.92.
• On Monday, January 6th, Amy Beth Vanduyn sold 1,311 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $34,885.71.
• On Tuesday, December 3rd, Amy Beth Vanduyn sold 25,447 shares of Phreesia stock. The shares were sold at an average price of $20.93, for a total transaction of $532,605.71.

Phreesia Stock Up 2.3 %

Phreesia stock opened at $27.89 on Friday. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $29.16. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The company’s 50 day moving average is $24.00 and its two-hundred day moving average is $23.00.

Phreesia (NYSE:PHR) last released its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The company had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The firm’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period in the prior year, the business earned ($0.58) EPS. Research analysts predict that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Institutional Investors Weigh In On Phreesia

A number of hedge funds have recently added to or reduced their stakes in PHR. Deerfield Management Company L.P. Series C acquired a new stake in Phreesia during the 2nd quarter worth approximately $4,078,000. Champlain Investment Partners LLC raised its holdings in shares of Phreesia by 4.1% in the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after purchasing an additional 97,847 shares in the last quarter. Sei Investments Co. raised its holdings in shares of Phreesia by 135.3% in the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after purchasing an additional 95,058 shares in the last quarter. Squarepoint Ops LLC raised its holdings in shares of Phreesia by 56.3% in the 2nd quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock valued at $5,308,000 after purchasing an additional 90,215 shares in the last quarter. Finally, State Street Corp raised its holdings in shares of Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after purchasing an additional 88,517 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently weighed in on PHR shares. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price target on shares of Phreesia in a research note on Friday, January 10th. Robert W. Baird dropped their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday, December 11th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and increased their price target for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. JMP Securities reissued a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Finally, KeyCorp increased their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research note on Wednesday, January 8th. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia currently has a consensus rating of “Buy” and a consensus target price of $31.00.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.